CSL – Algo Buy

CSL:ASX 1H21 NPAT of US$1.8bn. FY21 guidance retained at US$2.2bn, which implies a weaker 2H21.

We expect to see earnings upgraded prior to the completion of the 2H.

You’re not a member!  Trial today

CSL trades on a forward yield of 1%.

Ready to elevate your investing?

Join Investor Signals today and start your journey to better, more disciplined returns.